SMARCA4 and cancer: To identify glutamine transporters critical for these cancer cells, we analyzed the above DepMap CRISPR screen datasets (Fig. 1a) and identified SLC38A2, but not the other 7 amino acid transporters known to transport glutamine55–57, among the highly ranked candidates whose knockout was selectively lethal to SMARCA4/2-deficient ovarian cells (Fig. 5a, left).